1|Page
NR606 Week 5 Latest Update Exam | Questions and Verified
Answers | 100% Correct | Grade A +
Stimulant Medications: Methylphenidate - ANSWER -Low risk of
adverse effects
-Available formulations:
• Ritalin - available in immediate release (IR) and extended
release (XR) available in beads that may be sprinkled on food
for children who cannot swallow pills
• Concerta biphasic - combined immediate and delayed release
in one medication
• Daytrana - patch applied in AM and removed after 9 hour
Stimulant Medications: Dexmethylphenidate (Focalin) -
ANSWER -Available in IR and ER
-More potent than Ritalin
-High risk of adverse effects
Stimulant Medications: Amphetamine (Adzenys) - ANSWER -
available in orally disintegrating ER formula for children who
cannot swallow pills
,2|Page
-Avoid prescribing when an MAOI has been used within 14 days
Stimulant Medications: Dextroamphetamine (Adderall) -
ANSWER -Available in IR and extended-release formulations
-Often dosed in morning (IR or XR) with an evening or evening
prn (IR) dose if med effects diminish prior to end of school,
study or the workday
-Most abused & diverted prescription stimulant
Stimulant Medications: Lisdexamfetamine (Vyvanse) - ANSWER
-Biologically inactive until metabolized by the body (Prodrug)
-Less abuse & diversion potential than other stimulants
-Higher-cost medication
Non-stimulant medication: Atomoxetine (Strattera) - ANSWER -
Noradrenergic (NRI)
-Initial drug of choice for adults with ADHD
-no abuse potential
-tolerated well when prescribed in BID dosing
-appropriate choice for comorbid substance abuse
,3|Page
-may augment the effects of antidepressants & antianxiety
meds
-can be dosed at bedtime if fatigue is noted
-unlikely to worsen tics
Non-stimulant medication: Clonidine - ANSWER -α 2 agonist
• May be taken as monotherapy or with stimulant medications
-enhances precortical function for better mental focus
-appetite neutral
-may help with sleep disturbances, administer at bedtime
-adverse effects:
• sedation, brain fog
-monitor of BP closely during initial titration, risk of hypotension
-tapered to avoid rebound hypertension post discontinuation
Non-stimulant medication: guanfacine - ANSWER -α 2 agonist
• May be taken as monotherapy or with stimulant medications
-may also be used for children with tics, sleep disturbances, or
aggression
, 4|Page
-tolerability & convenience enhanced by once-daily oral
controlled-release formulation
-adverse effects:
• sedation, headache, decreased appetite
-reduced side-effect profile comparable to clonidine
-bedtime administration to avoid daytime sedation
Non-stimulant medication: Bupropion (Wellbutrin) - ANSWER -
Norepinephrine Dopamine Reuptake Inhibitor
-off-label use for ADHD in adults
-appropriate for clients with concurrent depression or tobacco
abuse
Attention-deficit/hyperactivity disorder (ADHD) - ANSWER -one
of the most common neuropsychiatric disorders
-approximately 9.4% of children in the U.S.
-more frequently males than females, ratio 2:1
-symptom burden mild to severe
-characterized by consistent pattern of inattention &/or
hyperactivity & impulsivity that interferes with functioning &
development
NR606 Week 5 Latest Update Exam | Questions and Verified
Answers | 100% Correct | Grade A +
Stimulant Medications: Methylphenidate - ANSWER -Low risk of
adverse effects
-Available formulations:
• Ritalin - available in immediate release (IR) and extended
release (XR) available in beads that may be sprinkled on food
for children who cannot swallow pills
• Concerta biphasic - combined immediate and delayed release
in one medication
• Daytrana - patch applied in AM and removed after 9 hour
Stimulant Medications: Dexmethylphenidate (Focalin) -
ANSWER -Available in IR and ER
-More potent than Ritalin
-High risk of adverse effects
Stimulant Medications: Amphetamine (Adzenys) - ANSWER -
available in orally disintegrating ER formula for children who
cannot swallow pills
,2|Page
-Avoid prescribing when an MAOI has been used within 14 days
Stimulant Medications: Dextroamphetamine (Adderall) -
ANSWER -Available in IR and extended-release formulations
-Often dosed in morning (IR or XR) with an evening or evening
prn (IR) dose if med effects diminish prior to end of school,
study or the workday
-Most abused & diverted prescription stimulant
Stimulant Medications: Lisdexamfetamine (Vyvanse) - ANSWER
-Biologically inactive until metabolized by the body (Prodrug)
-Less abuse & diversion potential than other stimulants
-Higher-cost medication
Non-stimulant medication: Atomoxetine (Strattera) - ANSWER -
Noradrenergic (NRI)
-Initial drug of choice for adults with ADHD
-no abuse potential
-tolerated well when prescribed in BID dosing
-appropriate choice for comorbid substance abuse
,3|Page
-may augment the effects of antidepressants & antianxiety
meds
-can be dosed at bedtime if fatigue is noted
-unlikely to worsen tics
Non-stimulant medication: Clonidine - ANSWER -α 2 agonist
• May be taken as monotherapy or with stimulant medications
-enhances precortical function for better mental focus
-appetite neutral
-may help with sleep disturbances, administer at bedtime
-adverse effects:
• sedation, brain fog
-monitor of BP closely during initial titration, risk of hypotension
-tapered to avoid rebound hypertension post discontinuation
Non-stimulant medication: guanfacine - ANSWER -α 2 agonist
• May be taken as monotherapy or with stimulant medications
-may also be used for children with tics, sleep disturbances, or
aggression
, 4|Page
-tolerability & convenience enhanced by once-daily oral
controlled-release formulation
-adverse effects:
• sedation, headache, decreased appetite
-reduced side-effect profile comparable to clonidine
-bedtime administration to avoid daytime sedation
Non-stimulant medication: Bupropion (Wellbutrin) - ANSWER -
Norepinephrine Dopamine Reuptake Inhibitor
-off-label use for ADHD in adults
-appropriate for clients with concurrent depression or tobacco
abuse
Attention-deficit/hyperactivity disorder (ADHD) - ANSWER -one
of the most common neuropsychiatric disorders
-approximately 9.4% of children in the U.S.
-more frequently males than females, ratio 2:1
-symptom burden mild to severe
-characterized by consistent pattern of inattention &/or
hyperactivity & impulsivity that interferes with functioning &
development
